| Selecting costimulatory domains for chimeric antigen receptors: functional and clinical considerations |
41 |
| Furin-mediated protein processing in infectious diseases and cancer |
41 |
| Recent novel approaches to limit oxidative stress and inflammation in diabetic complications |
21 |
| Human FOXP3(+) T regulatory cell heterogeneity |
17 |
| Endoplasmic reticulum stress in the development of multiple myeloma and drug resistance |
14 |
| Human gamma delta T-cell receptor repertoire is shaped by influenza viruses, age and tissue compartmentalisation |
12 |
| Genome-wide association studies of multiple sclerosis |
11 |
| gamma delta T-cell responses during HIV infection and antiretroviral therapy |
10 |
| The role of IL-22 in the resolution of sterile and nonsterile inflammation |
9 |
| Clinical chimeric antigen receptor-T cell therapy: a new and promising treatment modality for glioblastoma |
9 |
| Genome-wide association studies in Crohn's disease: Past, present and future |
8 |
| gamma delta T cells in cancer: a small population of lymphocytes with big implications |
8 |
| Dual targeting of RANKL and PD-1 with a bispecific antibody improves anti-tumor immunity |
8 |
| Tissue-specific tumor microenvironments influence responses to immunotherapies |
8 |
| Oxidative and endoplasmic reticulum stress in respiratory disease |
8 |
| Vaccinating for natural killer cell effector functions |
7 |
| Rapid loss of group 1 innate lymphoid cells during blood stage Plasmodium infection |
6 |
| High molecular weight hyaluronic acid: a two-pronged protectant against infection of the urogenital tract? |
6 |
| Switching on the green light for chimeric antigen receptor T-cell therapy |
6 |
| Regulatory T cells in renal disease |
6 |
| Idiopathic and immune-related pulmonary fibrosis: diagnostic and therapeutic challenges |
5 |
| A pathologic two-way street: how innate immunity impacts lung fibrosis and fibrosis impacts lung immunity |
5 |
| Chimeric antigen receptors designed to overcome transforming growth factor-beta-mediated repression in the adoptive T-cell therapy of solid tumors |
5 |
| Characterisation of anti-alpha toxin antibody levels and colonisation status after administration of an investigational human monoclonal antibody, MEDI against Staphylococcus aureus alpha toxin |
5 |
| Translation of peptidoglycan metabolites into immunotherapeutics |
5 |
| Harnessing host-virus evolution in antiviral therapy and immunotherapy |
5 |
| A high burden of cytomegalovirus marks poor vascular health in transplant recipients more clearly than in the general population |
5 |
| Emerging role of gamma delta T cells in vaccine-mediated protection from infectious diseases |
5 |
| Analysis of serum macrophage migration inhibitory factor and D-dopachrome tautomerase in systemic sclerosis |
4 |
| Accumulation of IL-17(+) V gamma 6(+) gamma delta T cells in pregnant mice is not associated with spontaneous abortion |
4 |
| Intercellular transfer of HLA-G: its potential in cancer immunology |
4 |
| Analysis of serum interleukin(IL)-1 alpha, IL-1 beta and IL-18 in patients with systemic sclerosis |
4 |
| The clock is ticking: the impact of ageing on T cell metabolism |
4 |
| The interplay of type 2 immunity, helminth infection and the microbiota in regulating metabolism |
3 |
| Rapid sequencing-based diagnosis of infectious bacterial species from meningitis patients in Zambia |
3 |
| Immunological observations and transcriptomic analysis of trimester-specific full-term placentas from three Zika virus-infected women |
3 |
| Post-transcriptional control of immune responses and its potential application |
3 |
| Effects of interleukin-6 receptor blockade on allergen-induced airway responses in mild asthmatics |
3 |
| Associations of pathogen-specific and host-specific characteristics with disease outcome in patients with Staphylococcus aureus bacteremic pneumonia |
3 |
| Novel differential linear B-cell epitopes to identify Zika and dengue virus infections in patients |
3 |
| The complex existence of gamma delta T cells following transplantation: the good, the bad and the simply confusing |
3 |
| Upregulation of HLA-E by dengue and not Zika viruses |
3 |
| Unravelling the molecular basis for regulatory T-cell plasticity and loss of function in disease |
3 |
| The role and therapeutic implications of T cells in cancer of the lung |
3 |
| Expression of IL-34 correlates with macrophage infiltration and prognosis of diffuse large B-cell lymphoma |
2 |
| Machine learning applied to whole-blood RNA-sequencing data uncovers distinct subsets of patients with systemic lupus erythematosus |
2 |
| Immune regulation of the unfolded protein response at the mucosal barrier in viral infection |
2 |
| Impact of pre-therapy glioblastoma multiforme microenvironment on clinical response to autologous CMV-specific T-cell therapy |
2 |
| Cross-reactive antibody-dependent cellular cytotoxicity antibodies are increased by recent infection in a household study of influenza transmission |
2 |
| Platelets regulate leucocyte responses to Toll-like receptor stimulation |
1 |
